Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa News Observer.
Press releases published on October 16, 2025
Newsmatics Highlights AI’s Role in News Distribution at Mid-Atlantic MarCom Summit
Panelists share tips on feeding AI systems to boost news distribution and content discoverability WASHINGTON , DC, UNITED STATES, October 16, 2025 /EINPresswire.com/ -- Artificial intelligence is rapidly reshaping how news is distributed and consumed, …
Les géants miniers d’Afrique de l’Ouest participeront au SIM Sénégal 2025, le plus grand événement minier régional
SIM Sénégal 2025, le plus grand événement minier d’Afrique de l’Ouest, se tiendra du 4 au 6 nov sous le patronage du Président Faye. DAKAR, DIAMNIADIO, SENEGAL, October 16, 2025 /EINPresswire.com/ -- SIM Sénégal 2025, le plus grand événement minier d' …
Apollo Files NI 43-101 Technical Report for the Calico Silver Project Updated Mineral Resource Estimate
VANCOUVER, British Columbia, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Apollo Silver Corp. (“Apollo” or the “Company”) (TSX.V:APGO, OTCQB:APGOF, Frankfurt:6ZF) is pleased to announce that it has filed the independent technical report for the updated Mineral …
West Africa’s mining giants to attend SIM Senegal 2025, the region’s largest mining event this year
SIM Senegal 2025, West Africa’s leading mining event will take place from the 4th – 6th November 2025. DAKAR, DIAMNIADIO, SENEGAL, October 16, 2025 /EINPresswire.com/ -- SIM Senegal 2025, West Africa’s leading mining event will take place from the 4th – …
Honoris South Africa Students Shine at the 2025 Loeries Awards
18 Wins Celebrate Creativity, Excellence, and the Power of Education for Impact® CAPE TOWN, SOUTH AFRICA, October 16, 2025 /EINPresswire.com/ -- Honoris United Universities proudly celebrates the outstanding achievements of its creative institutions, …
DPM Metals Announces Filing of Amended Technical Report for the Vareš Mine
TORONTO, Oct. 16, 2025 (GLOBE NEWSWIRE) -- DPM Metals Inc. (TSX: DPM, ASX: DPM) (ARBN: 689370894) (“DPM” or “the Company”) announces that, as a result of a review (the “Review”) of the existing technical report on the Vareš Mine by staff of the Ontario …
California Resources Corporation Breaks Ground on California’s First Carbon Capture and Storage Project
KERN COUNTY, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- California Resources Corporation (NYSE: CRC) today hosted a groundbreaking ceremony for Carbon TerraVault I (CTV I), the Golden State's first carbon capture and storage project, developed to reduce …
Helium Evolution Announces First Commercial Sales of Helium
CALGARY, Alberta, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Helium Evolution Incorporated (TSXV:HEVI) ("HEVI" or the "Company"), a Canadian-based helium exploration company focused on developing assets in southern Saskatchewan, is pleased to announce a major …
Lexeo Therapeutics Announces Proposed Offering of Common Stock and Pre-Funded Warrants
NEW YORK, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO) (the “Lexeo”), a clinical stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases, today announced that it has commenced an …
NY Roofing Hub Expands Professional Roofing Services Across New York City to Meet Growing Urban Demand
NEW YORK, NY, UNITED STATES, October 16, 2025 /EINPresswire.com/ -- NY Roofing Hub, a trusted New York roofing company, has announced an expansion of its professional New York roofing services to better serve residential and commercial property owners …
atai Life Sciences Announces Proposed Public Offering of Common Shares
NEW YORK and AMSTERDAM, Oct. 16, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company focused on transforming the treatment of mental health disorders, today announced the commencement …
atai Life Sciences and Beckley Psytech Announce U.S. FDA Breakthrough Therapy Designation Granted to BPL-003, Underscoring its Potential in Treatment-Resistant Depression
Breakthrough Therapy designation recognizes the potential of BPL-003 to deliver substantial improvement over existing therapies for patients with treatment-resistant depression FDA designation follows previously announced Phase 2b topline data which showed …
Lite Strategy Celebrates 14th Anniversary of Litecoin, Taps Institutional Signals Ahead of 2026
SAN DIEGO, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Lite Strategy, Inc. (NASDAQ: LITS) (“Lite Strategy” or “LITS”), the first U.S.-listed public company to adopt Litecoin as its primary reserve asset, joins the digital asset community in celebrating the 14th …
SONORO GOLD ANNOUNCES INCREASE IN PRIVATE PLACEMENT TO $4 MILLION
“THIS PRESS RELEASE, REQUIRED BY APPLICABLE CANADIAN LAWS, IS NOT FOR DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.” VANCOUVER, Canada, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Sonoro Gold Corp. (TSXV: SGO | OTCQB: SMOFF | FRA: …
Praxis Precision Medicines, Inc. Announces Proposed Public Offering
BOSTON, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by …
Le R&D Day de Cellectis souligne le potentiel de lasmé-cel pour combler un besoin médical majeur non satisfait chez les patients atteints de LAL-B en rechute ou réfractaire
○ Efficacité : taux de réponse global (ORR) de 68 % avec le Process 2 de lasmé-cel (P2) (n=22) ; 83 % à la dose recommandée de Phase 2 (RP2D, n=12) ; et 100 % dans la population cible de Phase 2 (n=9)1 ○ Sécurité : en Phase 1 (n=40), lasmé-cel a été …
Cellectis’ R&D Day Highlights Lasme-cel’s Potential to Address Significant Unmet Need for Patients with r/r B-ALL
○ Efficacy: ORR of 68% with lasme-cel Process 2 (n=22), 83% at RP2D (n=12) and 100% in the target Phase 2 population (n=9) ○ Safety: in Phase 1 (n=40), lasme-cel was generally well-tolerated (including 1 case of grade 2 IEC-HS which resolved) ○ Durability …
聽證會取消後，Apollomics 宣佈繼續於 The Nasdaq Stock Market 維持其上市地位
加州福斯特城, Oct. 17, 2025 (GLOBE NEWSWIRE) -- 總部設於加州的 Apollomics Inc. (Nasdaq: APLM) (「Apollomics」或「公司」) 是一家晚期臨床生物製藥公司，開發多種腫瘤候選藥物對抗難以根治及對治療有抗藥性的癌症。該公司較早時宣佈已向 The Nasdaq Stock Market, LLC (簡稱「Nasdaq」) 之上市資格人員（簡稱「上市資格人員」）提交申請，對先前收到之除牌通知提出上訴，並要求在 Nasdaq …
Forsys Announces Closing of Bought Deal LIFE Private Placement for Gross Proceeds of C$18.9 Million
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES. TORONTO, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Forsys Metals Corp. ( …